One of the critical pathways abnormally activated in many cancers is the phosphatidylinositol 3-kina-se/protein kinase-b/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling cascade, which results in varying degrees of interference with cell proliferation and regulation of various cellular processes [59]. The gene discussed is MTOR; the disease is cancer.